Psoriasis: talking points from recent clinical trials.

Chiricozzi A, Bellinato F, Romita P, Gisondi P

DOI: 10.1080/13543784.2022.2160314
Published: 2022 Dec
Container: Expert opinion on investigational drugs
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/13543784.2022.2160314,
  title = {Psoriasis: talking points from recent clinical trials.},
  author = {Chiricozzi A and Bellinato F and Romita P and Gisondi P},
  year = {2022},
  journal = {Expert opinion on investigational drugs},
  doi = {10.1080/13543784.2022.2160314},
  url = {https://doi.org/10.1080/13543784.2022.2160314}
}

RIS

TY  - JOUR
TI  - Psoriasis: talking points from recent clinical trials.
AU  - Chiricozzi A
AU  - Bellinato F
AU  - Romita P
AU  - Gisondi P
PY  - 2022
JO  - Expert opinion on investigational drugs
DO  - 10.1080/13543784.2022.2160314
UR  - https://doi.org/10.1080/13543784.2022.2160314
ER  -

APA

A, C., F, B., P, R., & P, G. (2022). Psoriasis: talking points from recent clinical trials.. Expert opinion on investigational drugs. https://doi.org/10.1080/13543784.2022.2160314

Source records

pubmed · retrieved 2026-09-25T12:34:04.196Z